Download PDF
Facial Plast Surg 2016; 32(03): 261-268
DOI: 10.1055/s-0036-1584215
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Future of Fractional Lasers

Uwe Paasch
1   Department for Dermatology, Venerology and Allergology, University of Leipzig, Leipzig, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
01 June 2016 (online)

   Permissions and Reprints

Abstract

Recent insights to the potential of fractional skin treatments have established standard laser procedures to treat aged, sun-damaged skin and scars. On top of this, the concept has been extended to fibrosing conditions, to remove foreign bodies and to treat inflammatory skin diseases. The biggest potential, however, is foreseen with the option of a contact-free temporary opening of the epidermal barrier (TOR, German: gate) to promote new and intensified treatment regimen. To date these concepts are predominantly experimental, although first clinical studies already show a better response rate if actinic keratoses are treated by fractional laser-intensified photodynamic therapy (PDT) in comparison to the conventional PDT. Possible risks may arise due to the fact that fractional laser home devices are at hand. Used in conjunction with topicals of all origins, toxic and allergic reactions may occur. Principles of current fractional laser interventions are presented as facts while visions are given as future indications.

Keywords

skin - fractional - laser - drug delivery - skin cancer
 

  • References

  • 1 Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34 (5) 426-438
    CrossrefPubMedGoogle Scholar
  • 2 Paasch U, Haedersdal M. Laser systems for ablative fractional resurfacing. Expert Rev Med Devices 2011; 8 (1) 67-83
    CrossrefPubMedGoogle Scholar
  • 3 Grunewald S, Bodendorf M, Illes M, Kendler M, Simon JC, Paasch U. In vivo wound healing and dermal matrix remodelling in response to fractional CO(2) laser intervention: clinicopathological correlation in non-facial skin. Int J Hyperthermia 2011; 27 (8) 811-818
    CrossrefPubMedGoogle Scholar
  • 4 Polder KD, Harrison A, Eubanks LE, Bruce S. 1,927-nm fractional thulium fiber laser for the treatment of nonfacial photodamage: a pilot study. Dermatol Surg 2011; 37 (3) 342-348
    CrossrefPubMedGoogle Scholar
  • 5 Skovbølling Haak C, Illes M, Paasch U, Hædersdal M. Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin model. Lasers Med Sci 2011; 26 (4) 465-471
    CrossrefPubMedGoogle Scholar
  • 6 Paasch U, Bodendorf MO, Grunewald S. Dermatologische Lasertherapie: Fraktionale Laser. Berlin: KVM Verlag; 2011
    Google Scholar
  • 7 Brauer JA, Geronemus RG. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol 2013; 16 (1) 51-54
    CrossrefPubMedGoogle Scholar
  • 8 Tsilika K, Bahadoran P, Passeron T. Superficial lymphangioma treated with fractional ablative laser: a case report with clinical and reflectance confocal microscopy evaluation. Dermatol Surg 2013; 39 (1, Pt 1): 141-143
    CrossrefPubMedGoogle Scholar
  • 9 Weiss ET, Brauer JA, Anolik R , et al. 1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic option. J Am Acad Dermatol 2013; 68 (1) 98-102
    CrossrefPubMedGoogle Scholar
  • 10 Helsing P, Togsverd-Bo K, Veierød MB, Mørk G, Haedersdal M. Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol 2013; 169 (5) 1087-1092
    CrossrefPubMedGoogle Scholar
  • 11 Ibrahimi OA, Syed Z, Sakamoto FH, Avram MM, Anderson RR. Treatment of tattoo allergy with ablative fractional resurfacing: a novel paradigm for tattoo removal. J Am Acad Dermatol 2011; 64 (6) 1111-1114
    CrossrefPubMedGoogle Scholar
  • 12 Baker DJ, Wijshake T, Tchkonia T , et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479 (7372) 232-236
    CrossrefPubMedGoogle Scholar
  • 13 Haedersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR. Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 2010; 42 (2) 113-122
    CrossrefPubMedGoogle Scholar
  • 14 Haedersdal M, Katsnelson J, Sakamoto FH , et al. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 2011; 43 (8) 804-813
    CrossrefPubMedGoogle Scholar
  • 15 Lee WR, Shen SC, Al-Suwayeh SA, Yang HH, Yuan CY, Fang JY. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Control Release 2011; 153 (3) 240-248
    CrossrefPubMedGoogle Scholar
  • 16 Beltraminelli H, Dietrich N, Hunziker T. Fractional transepidermal delivery: a histological analysis. Dermatology 2011; 223 (4) 321-324
    CrossrefPubMedGoogle Scholar
  • 17 Togsverd-Bo K, Lerche CM, Philipsen PA, Poulsen T, Wulf HC, Haedersdal M. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. Exp Dermatol 2012; 21 (4) 260-264
    CrossrefPubMedGoogle Scholar
  • 18 Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166 (6) 1262-1269
    CrossrefPubMedGoogle Scholar
  • 19 Wu X, Landfester K, Musyanovych A, Guy RH. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol 2010; 23 (3) 117-123
    CrossrefPubMedGoogle Scholar
  • 20 Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2 (12) 751-760
    CrossrefPubMedGoogle Scholar
  • 21 Haedersdal M, Togsverd-Bo K, Paasch U. Case reports on the potential of fractional laser-assisted photodynamic therapy for basal cell carcinomas. Lasers Med Sci 2012; 27 (5) 1091-1093
    CrossrefPubMedGoogle Scholar
  • 22 Helbig D, Simon JC, Paasch U. Photodynamic therapy and the role of heat shock protein 70. Int J Hyperthermia 2011; 27 (8) 802-810
    CrossrefPubMedGoogle Scholar
  • 23 Helbig D, Paasch U. Molecular changes during skin aging and wound healing after fractional ablative photothermolysis. Skin Res Technol 2011; 17 (1) 119-128
    CrossrefPubMedGoogle Scholar
  • 24 Helbig D, Moebius A, Simon JC, Paasch U. Nonablative skin rejuvenation devices and the role of heat shock protein 70: results of a human skin explant model. J Biomed Opt 2010; 15 (3) 038002
    CrossrefPubMedGoogle Scholar
  • 25 Reddy KK, Brauer JA, Anolik R , et al. Calcium hydroxylapatite nodule resolution after fractional carbon dioxide laser therapy. Arch Dermatol 2012; 148 (5) 634-636
    CrossrefPubMedGoogle Scholar
  • 26 Cho S, Jung JY, Shin JU, Lee JH. Silicone-induced foreign body reaction of the face successfully treated using nonablative 1,550-nm erbium-glass and ablative 10,600-nm carbon dioxide fractional lasers. Dermatol Surg 2012; 38 (10) 1744-1746
    CrossrefPubMedGoogle Scholar
  • 27 Weiss ET, Geronemus RG. Combining fractional resurfacing and Q-switched ruby laser for tattoo removal. Dermatol Surg 2011; 37 (1) 97-99
    CrossrefPubMedGoogle Scholar
  • 28 Wang CC, Huang CL, Sue YM, Lee SC, Leu FJ. Treatment of cosmetic tattoos using carbon dioxide ablative fractional resurfacing in an animal model: a novel method confirmed histopathologically. Dermatol Surg 2013; 39 (4) 571-577
    CrossrefPubMedGoogle Scholar
  • 29 Wang CC, Huang CL, Lee SC, Sue YM, Leu FJ. Treatment of cosmetic tattoos with nonablative fractional laser in an animal model: a novel method with histopathologic evidence. Lasers Surg Med 2013; 45 (2) 116-122
    CrossrefPubMedGoogle Scholar
  • 30 Anitha B, Mysore V. Lichen amyloidosis: novel treatment with fractional ablative 2,940 nm Erbium: YAG laser treatment. J Cutan Aesthet Surg 2012; 5 (2) 141-143
    CrossrefPubMedGoogle Scholar
  • 31 Kineston D, Kwan JM, Uebelhoer NS, Shumaker PR. Use of a fractional ablative 10.6-μm carbon dioxide laser in the treatment of a morphea-related contracture. Arch Dermatol 2011; 147 (10) 1148-1150
    CrossrefPubMedGoogle Scholar
  • 32 Isarría MJ, Cornejo P, Muñoz E, Royo de la Torre J, Moraga JM. Evaluation of clinical improvement in acne scars and active acne in patients treated with the 1540-nm non-ablative fractional laser. J Drugs Dermatol 2011; 10 (8) 907-912
    PubMedGoogle Scholar
  • 33 Park J, Choi MJ, Goo B, Cho SB. Refractory pyoderma gangrenosum effectively treated using a 10,600-nm carbon dioxide fractional laser. Dermatol Surg 2013; 39 (3, Pt 1) 477-479
    CrossrefPubMedGoogle Scholar
  • 34 Paasch U, Bodendorf MO, Grunewald S. Dermatologische Lasertherapie: Fraktionale Laser. Berlin: KVM Verlag; 2012
    Google Scholar